Phospho-GRIA2 (S880) Antibody

What is GRIA2 and what role does S880 phosphorylation play in its function?

GRIA2 (also known as GluA2, GluR2) is a subunit of the AMPA-type glutamate receptor that functions as a ligand-gated cation channel in the central nervous system. It plays a crucial role in fast excitatory synaptic transmission by responding to glutamate and glutamatergic agonists like AMPA, quisqualic acid, and kainic acid .

Phosphorylation at serine 880 (S880) is a critical post-translational modification that regulates GRIA2 trafficking. When phosphorylated at S880, GRIA2 shows decreased binding to the scaffolding protein GRIP1, while maintaining its interaction with PICK1 . This change promotes AMPAR internalization from the synaptic membrane, potentially contributing to synaptic depression mechanisms. In experimental models, enhanced GluA2 S880 phosphorylation correlates with reduced surface expression of AMPA receptors .

How do researchers distinguish between total GRIA2 and the phosphorylated S880 form?

Researchers use phospho-specific antibodies that selectively recognize the phosphorylated S880 residue of GRIA2. These antibodies are typically developed using synthetic phosphopeptides corresponding to residues surrounding S880 of GRIA2 . The specificity of these antibodies can be verified through several methods:

• Lambda phosphatase treatment to remove phosphorylation and confirm signal loss

• Comparative analysis with samples from phospho-deficient mutants (e.g., S880A or S880F)

• Western blotting with serial dilutions of phosphorylated and non-phosphorylated peptides

• Parallel detection with total GRIA2 antibodies to compare relative phosphorylation levels

Researchers should always run appropriate controls including total GRIA2 detection when studying phosphorylation to normalize for total protein expression changes.

What are the recommended applications for Phospho-GRIA2 (S880) antibodies?

According to the search results, Phospho-GRIA2 (S880) antibodies are primarily recommended for Western blotting (WB) applications . Some specific application parameters include:

• Dilution ranges typically between 1:500-1:2000 for Western blot applications

• Most antibodies recognize phosphorylated GRIA2 from human, mouse, and rat samples

• Sample types commonly used include brain tissue lysates, neuronal cultures, and cell lines expressing GRIA2

• Some antibodies have also been validated for immunofluorescence or immunocytochemistry applications

It's important to note that the optimal working dilution should be determined empirically by each researcher for their specific experimental conditions .

How does S880 phosphorylation affect GRIA2's interaction with scaffolding proteins?

Phosphorylation of GRIA2 at S880 functions as a molecular switch that regulates the receptor's interaction with PDZ domain-containing scaffolding proteins:

• When S880 is phosphorylated, GRIA2 binding to GRIP1/2 is significantly reduced

• pS880 maintains or enhances binding to PICK1, another PDZ domain protein

• This differential binding pattern controls whether AMPA receptors are stabilized at synapses or undergo internalization

• In GRIP1/2 knockout mice, increased GluA2-S880 phosphorylation was observed, suggesting a potential compensatory mechanism or feedback regulation

This phosphorylation-dependent protein interaction mechanism provides a fine-tuned regulation of synaptic strength by controlling the pool of surface available receptors.

What is the relationship between phosphorylation at S880 and other phosphorylation sites on GRIA2?

GRIA2 contains multiple phosphorylation sites that are regulated independently and may have distinct or coordinated functions:

• Tyrosine phosphorylation at Y876 (adjacent to S880) is also important for GRIA2 trafficking and internalization

• Studies show that Y876 and S880 phosphorylation can be regulated independently, with different stimuli affecting each site specifically

• Analysis using site-specific antibodies demonstrated that phosphorylation status at one site (S880 or Y876) doesn't affect antibody recognition of the other site

• GRIA2 also contains phosphorylation sites at Y869 and Y873, which can be detected together with Y876 using combined antibodies

• The GluA3 subunit contains analogous phosphorylation sites (S885 corresponds to S880 in GRIA2)

Researchers studying GRIA2 modification should consider the potential for crosstalk between different phosphorylation events.

How do protein phosphatases and kinases regulate GRIA2 S880 phosphorylation?

GRIA2 S880 phosphorylation is regulated by a balance of kinase and phosphatase activities:

• Protein Kinase C (PKC) is a major kinase that phosphorylates GRIA2 at S880

• PKC activation using phorbol esters like PMA increases S880 phosphorylation

• Protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A) are the main phosphatases that dephosphorylate GluA2 S880

• PP2A oxidation inhibits its ability to dephosphorylate GluA2 S880, as shown in studies with protein disulfide isomerase (PDI) knockdown

• The redox status of phosphatases can influence their activity toward GRIA2 S880

This dynamic regulation provides multiple pathways for neurons to control GRIA2 phosphorylation in response to different stimuli and signaling cascades.

What are the critical validation steps for Phospho-GRIA2 (S880) antibodies?

Proper validation of phospho-specific antibodies is crucial for result interpretation:

Many commercial antibodies claim to be validated through these methods, but researchers should verify specificity in their own experimental systems .

What experimental approaches can manipulate GRIA2 S880 phosphorylation?

Researchers can modify GRIA2 S880 phosphorylation levels through several approaches:

• Pharmacological interventions:

  • PKC activators (PMA, phorbol esters) increase S880 phosphorylation

  • Protein phosphatase inhibitors (okadaic acid for PP2A) increase phosphorylation

  • PDI knockdown enhances S880 phosphorylation by increasing PP2A oxidation

• Genetic manipulations:

  • Phospho-deficient mutants (S880A, S880F) prevent phosphorylation

  • Phospho-mimetic mutants (S880D, S880E) simulate constitutive phosphorylation

  • Knockout of interacting proteins like GRIP1/2 affects S880 phosphorylation levels

• Physiological manipulations:

  • Neuronal activity modulation (TTX, bicuculline) can alter S880 phosphorylation

  • Ischemic conditions increase phosphorylation at multiple GRIA2 sites

  • Kainic acid-induced seizures affect phosphorylation status

These approaches allow researchers to establish causal relationships between S880 phosphorylation and functional outcomes.

What sample preparation considerations are critical for detecting GRIA2 S880 phosphorylation?

Reliable detection of phosphorylated proteins requires careful sample preparation:

• Rapid sample collection and processing is essential as phosphorylation states can change quickly

• Include phosphatase inhibitors (sodium orthovanadate, sodium fluoride, β-glycerophosphate) in lysis buffers

• For brain tissue, consider subcellular fractionation to enrich for postsynaptic density (PSD) proteins

• Full denaturing lysis conditions may be necessary to separate GRIA2 from interacting proteins

• Different extraction methods may yield varying results:

  • Postnuclear supernatant (S1) fraction for total protein assessment

  • PSD pellet enrichment for synaptic proteins

  • Surface biotinylation for membrane expression analysis

Proper sample preparation is crucial as phosphorylation can be lost during handling or masked by interacting proteins.

How do alterations in GRIA2 S880 phosphorylation affect synaptic function?

Changes in GRIA2 S880 phosphorylation have significant functional consequences:

• Increased S880 phosphorylation promotes AMPAR internalization, potentially contributing to long-term depression (LTD)

• In GRIP1/2 knockout mice, increased GluA2-S880 phosphorylation was associated with altered social behaviors and enhanced social interactions

• PDI knockdown increased S880 phosphorylation and reduced AMPAR surface expression, linking redox regulation to receptor trafficking

• S880 phosphorylation can act as a molecular switch that controls whether receptors are recycled back to the membrane or targeted for degradation

• The S880 site is crucial for synaptic scaling mechanisms, with phosphorylation status influencing homeostatic plasticity

These functional outcomes highlight the importance of S880 phosphorylation in both normal synaptic physiology and pathological conditions.

What are common pitfalls in interpreting Phospho-GRIA2 (S880) antibody results?

Researchers should be aware of several challenges when interpreting results:

• Antibody cross-reactivity with similar phosphorylation sites on other AMPAR subunits, particularly GluA3 S885

• The presence of residual signal in phospho-deficient mutants that may be due to recognition of related subunits

• Changes in total GRIA2 levels that could be misinterpreted as phosphorylation changes if not properly normalized

• Phosphorylation status at S880 can be influenced by sample preparation methods and post-mortem changes

• The relationship between phosphorylation level detected by immunoblotting and functional consequences may not be linear

• Differences in antibody affinity between commercial sources may lead to inconsistent results across studies

Careful experimental design with appropriate controls is essential for accurate interpretation.

How can researchers connect GRIA2 S880 phosphorylation to disease mechanisms?

GRIA2 S880 phosphorylation has been implicated in several neurological conditions:

• Altered social behaviors and enhanced social interactions were observed in mice with dysregulated GRIA2 S880 phosphorylation

• Ischemic conditions increase phosphorylation at multiple GRIA2 sites, potentially contributing to excitotoxicity

• PDI augmentation of kainic acid-induced seizure activity involves modulation of GRIA2 phosphorylation

• Changes in AMPAR trafficking mediated by S880 phosphorylation may contribute to synaptic dysfunction in neurodevelopmental disorders

• Dysregulation of the balance between phosphorylation and dephosphorylation pathways could be involved in conditions with aberrant synaptic plasticity

When investigating disease mechanisms, researchers should establish clear links between molecular changes in S880 phosphorylation and functional or behavioral outcomes through multiple lines of evidence.

How do different stimuli distinctly regulate phosphorylation of GRIA2 at S880 versus other sites?

Different stimulation paradigms can selectively regulate specific phosphorylation sites:

• Tyrosine phosphatase inhibitors (sodium orthovanadate) increase GRIA2 Y876 phosphorylation without necessarily affecting S880

• Src family kinase inhibitors (PP2) decrease Y876 phosphorylation specifically

• PKC activators (PMA) primarily increase S880 phosphorylation

• Combined stimulation shows that Y876 and S880 phosphorylation can be regulated independently, suggesting distinct signaling pathways

• Neuronal activity modulation through TTX or bicuculline treatment can differentially affect various phosphorylation sites

• Redox status modulation (PDI knockdown) affects PP2A activity and consequently S880 phosphorylation

This differential regulation provides neurons with multiple mechanisms to fine-tune receptor function in response to diverse stimuli.

What technical advances are improving detection and quantification of GRIA2 S880 phosphorylation?

Recent methodological improvements have enhanced phosphorylation research:

• Development of highly specific phospho-antibodies that minimize cross-reactivity with similar sites

• Phospho-specific mass spectrometry approaches like PhosphoScan for site identification

• Improved purification methods for antibodies that can recognize phosphorylation in the presence of neighboring mutations

• Quantitative western blotting with internal normalization controls

• Combination of biochemical assays with imaging techniques to visualize phosphorylation in situ

• Genetic models with phospho-deficient mutations that serve as validation tools

These advances allow for more precise quantification and functional correlation of phosphorylation events.

How does GRIA2 S880 phosphorylation interact with other post-translational modifications?

GRIA2 undergoes multiple post-translational modifications that may interact functionally:

• Palmitoylation of GRIA2 at different sites (Cys-610, Cys-836) affects trafficking and endocytosis

• Ubiquitination by RNF167 leads to GRIA2 degradation and may be influenced by phosphorylation status

• N-glycosylation of GRIA2 affects its folding and surface expression

• Phosphorylation at Y876 is required for interaction with IQSEC1 and ARF6 activation, leading to AMPAR internalization

• S880 phosphorylation status may influence the accessibility of other modification sites

• Redox modifications of interacting proteins (e.g., PP2A oxidation) indirectly impact S880 phosphorylation

Understanding these interacting modifications provides a more complete picture of how GRIA2 function is regulated in complex cellular environments.